Moxifloxacin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Moxifloxacin Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 10/29/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-850-74
- Dosage Form
- Injection
- Presentation
- Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74)
- Initial Posting
- 10/29/2025
- Revised Date